ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - methylphenidate hydrochloride - טבליות בשחרור ממושך - methylphenidate hydrochloride 54 mg - methylphenidate

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - methylphenidate hydrochloride - טבליות בשחרור ממושך - methylphenidate hydrochloride 54 mg - methylphenidate

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - duloxetine as hydrochloride - duloxetine as hydrochloride 30 mg - duloxetine

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - duloxetine as hydrochloride - duloxetine as hydrochloride 60 mg - duloxetine

ישראל - עברית - Ministry of Health

rafa laboratories ltd - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (gerd) or duodenal ulcer. prevention of relapse in patients with gerd or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - lansoprazole - קפסולות - lansoprazole 15 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (gerd) or duodenal ulcer. prevention of relapse in patients with gerd or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine - חוקן - mesalazine 4 g / 60 g - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine - caplets - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine - פתילות - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine - caplets - mesalazine 1000.0 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.